The online version of this article (doi:10.1186/s12872-017-0510-9) contains supplementary material, which is available to authorized users.
The prognostic value of heart failure specific and global health status before and after left ventricular assist device (LVAD) implantation in the usual care setting is not well studied.
We included 3,836 continuous-flow LVAD patients in the INTERMACS registry. Health status was measured pre-operatively and 3 months post-LVAD using the Kansas City Cardiomyopathy Questionnaire (KCCQ) and EuroQol visual analog scale (VAS). Primary outcomes were mortality/rehospitalization. Inverse propensity weighting was used to minimize bias from missing data.
Pre-operative global and heart failure-specific health status were very poor: KCCQ median 34.6 (IQR 21.4-50.5); VAS median 43 (interquartile range (IQR) 25–65). Health status measures improved 3 months after LVAD placement: KCCQ median 69.3 (IQR 54.2-82.3); VAS median 75 (IQR 60–85). Pre-operative health status was not associated with death (unadjusted HR for lowest vs. highest score quartiles: 1.09 (0.85-1.41) KCCQ; 1.12 (0.85-1.49) VAS) or rehospitalization (unadjusted HR 0.83 (0.72-0.96) KCCQ; 0.99 (0.85-1.16) VAS). Three-month KCCQ was associated with mortality (unadjusted HR 2.17 (1.47-3.21); VAS was not (1.43 (0.94-2.17). Three-month KCCQ added incremental discriminatory value to the HeartMate II Risk Score for death (c-stat 0.60 to 0.66); VAS did not (c-stat 0.59 to 0.60). Three-month health status was associated with rehospitalization (unadjusted HR 1.31 (1.15-1.57) KCCQ; 1.24 (1.05-1.46) VAS), but did not add incremental discriminatory value (c-stat 0.52 to 0.55 and 0.54, respectively).
These real-world data suggest that pre-operative health status has limited association with outcomes after LVAD. However, persistently low health status after surgery may independently signal higher risk for subsequent death. Further study is needed to determine the clinical utility of routinely collected health status data after LVAD implantation.
Additional file 1: Comparison of baseline characteristics between patients with and without baseline Kansas City Cardiomyopathy Questionnaire (KCCQ) data. Baseline (or pre-operative) characteristics of patients who did and did not have baseline KCCQ data available. (DOCX 92 kb)12872_2017_510_MOESM1_ESM.docx
Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, Miller MA, Baldwin JT, Young JB. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015;34:1–10. CrossRef
Levy WC. Potential Clinical Applications of the HeartMate II Risk Score. JAC. 2013;61:322–4. CrossRef
Thomas SS, Nahumi N, Han J, Lippel M, Colombo P, Yuzefpolskaya M, Takayama H, Naka Y, Uriel N, Jorde UP. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score. J Heart Lung Transplant. 2014;33:675–81. CrossRefPubMed
Adamo L, Nassif M, Tibrewala A, Novak E, Vader J, Silvestry SC, Itoh A, Ewald GA, Mann DL, LaRue SJ. The Heartmate Risk Score Predicts Morbidity and Mortality in Unselected Left Ventricular Assist Device Recipients and Risk Stratifies INTERMACS Class 1 Patients. JACC. 2015;3:1–8.
Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, Morgan JA, Arabia F, Bauman ME, Buchholz HW, Deng M, Dickstein ML, El-Banayosy A, Elliot T, Goldstein DJ, Grady KL, Jones K, Hryniewicz K, John R, Kaan A, Kusne S, Loebe M, Massicotte MP, Moazami N, Mohacsi P, Mooney M, Nelson T, Pagani F, Perry W, Potapov EV, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;2013:157–87. CrossRef
Rumsfeld JS, Alexander KP, Goff DC, Graham MM, Ho PM, Masoudi FA, Moser DK, Roger VL, Slaughter MS, Smolderen KG, Spertus JA, Sullivan MD, Treat-Jacobson D, Zerwic JJ, on behalf of the American Heart Association Council on Quality of Care and Outcomes Research, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Stroke Council: Cardiovascular Health: The Importance of Measuring Patient-Reported Health Status: A Scientific Statement From the American Heart Association. Circulation 2013, 127:2233–2249.
Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS, Peterson ED, Masoudi FA, Krumholz HM, Havranek EP, Conard MW, Williams RE. Cardiovascular Outcomes Research Consortium: Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006;47:752–6. CrossRefPubMed
Konstam V, Salem D, Pouleur H, Kostis J, Gorkin L, Shumaker S, Mottard I, Woods P, Konstam MA, Yusuf S. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol. 1996;78:890–5. CrossRefPubMed
Rumsfeld JS, MaWhinney S, McCarthy M, Shroyer AL, VillaNueva CB, O'Brien M, Moritz TE, Henderson WG, Grover FL, Sethi GK, Hammermeister KE. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA. 1999;281:1298–303. CrossRefPubMed
Group EQ. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. CrossRef
Ambrosy AP, Hernandez AF, Armstrong PW, Butler J, Dunning A, Ezekowitz JA, Felker GM, Greene SJ, Kaul P, McMurray JJ, Metra M, O'Connor CM, Reed SD, Schulte PJ, Starling RC, Wilson Tang WH, Voors AA, Mentz RJ: The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2015.
Flynn KE, Lin L, Ellis SJ, Russell SD, Spertus JA, Whellan DJ, Piña IL, Fine LJ, Schulman KA, Weinfurt KP. Outcomes, health policy, and managed care: Relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure. Am Heart J. 2009;158:S64–71. CrossRefPubMedPubMedCentral
Grady KL, Andrei A-C, Naftel DC, Meyers S, Dew MA, Idrissi KA, Weidner G, Wissman S, Kirklin JK, Spertus J: Abstract: Approaches to Missing Data Due to Illness Severity in Health-related Quality of Life Assessment. Circ Cardiovasc Qual Outcomes 2015;8:A277.
Arnold SV, Jones PG, Allen LA, Cohen DJ, Fendler TJ, Holtz JE, Aggarwal S, Spertus JA. Frequency of Poor Outcome (Death or Poor Quality of Life) After Left Ventricular Assist Device for Destination Therapy: Results From the INTERMACS Registry. Circulation heart failure. 2016;9:e002800. CrossRefPubMed
Loghmanpour NA, Kanwar MK, Druzdzel MJ, Benza RL, Murali S, Antaki JF: A New Bayesian Network-Based Risk Stratification Model for Prediction of Short-term and Long-term LVAD Mortality. ASAIO J. 2015;1:313-323.
Grady KL, Naftel D, Stevenson L, Amanda Dew M, Weidner G, Pagani FD, Kirklin JK, Myers S, Baldwin T, Young J. Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation. J Heart Lung Transplant. 2014;33:412–21. CrossRefPubMed
Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park SJ, John R, Conte JV, Farrar DJ. Slaughter MS, for the HeartMate II Clinical Investigators: Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients. J Am Coll Cardiol. 2010;55:1826–34. CrossRefPubMed
Smedira NG, Hoercher KJ, Lima B, Mountis MM, Starling RC, Thuita L, Schmuhl DM, Blackstone EH. Unplanned Hospital Readmissions After HeartMate II Implantation. JACC. 2013;1:31–9. PubMed
Grady KL, Magasi S, Hahn EA, Buono S, McGee EC, Yancy C. Health-related quality of life in mechanical circulatory support: Development of a new conceptual model and items for self-administration. J Heart Lung Transplant. 2015;34:1–13. CrossRef
- Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation
Kelsey M. Flint
John A. Spertus
Timothy J. Fendler
Larry A. Allen
- BioMed Central
Neu im Fachgebiet Kardiologie
Mail Icon II